ArticleResearch (Washington, D.C.)2025

EDEM1 Inhibits Endoplasmic Reticulum Stress to Induce Doxorubicin Resistance through Accelerating ERAD and Activating Keap1/Nrf2 Antioxidant Pathway in Triple-Negative Breast Cancer.

Yajie Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.